# Implantable Cardioverter-Defibrillator Use in the VA System

> **NCT01217827** · PHASE3 · COMPLETED · sponsor: **Stanford University** · enrollment: 89 (actual)

## Conditions studied

- Cardiomyopathies

## Interventions

- **BEHAVIORAL:** Clinical Reminder

## Key facts

- **NCT ID:** NCT01217827
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-01
- **Final completion:** 2013-12
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2021-05-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01217827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01217827, "Implantable Cardioverter-Defibrillator Use in the VA System". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01217827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*